Virological response to nucleos(t)ide analogues treatment in chronic hepatitis B patients is associated with Bacteroides-dominant gut microbiome

拟杆菌 熊去氧胆酸 脆弱类杆菌 肠道菌群 微生物群 失调 微生物学 普雷沃菌属 内科学 拟杆菌科 生物 医学 免疫学 细菌 抗生素 生物信息学 遗传学
作者
Saisai Zhang,Hau-Tak Chau,Hein M. Tun,Fung‐Yu Huang,Danny Ka‐Ho Wong,Lung‐Yi Mak,Man‐Fung Yuen,Wai‐Kay Seto
出处
期刊:EBioMedicine [Elsevier]
卷期号:103: 105101-105101 被引量:4
标识
DOI:10.1016/j.ebiom.2024.105101
摘要

BackgroundGut dysbiosis is present in chronic hepatitis B virus (HBV) infection. In this study, we integrated microbiome and metabolome analysis to investigate the role of gut microbiome in virological response to nucleos(t)ide analogues (NAs) treatment.MethodsChronic HBV patients were prospectively recruited for steatosis and fibrosis assessments via liver elastography, with full-length 16S sequencing performed to identify the compositional gut microbiota differences. Fasting plasma bile acids were quantified by liquid chromatography-tandem mass spectrometry.FindingsAll patients (n = 110) were characterized into three distinct microbial clusters by their dominant genus: c-Bacteroides, c-Blautia, and c-Prevotella. Patients with c-Bacteroides had a higher plasma ursodeoxycholic acids (UDCA) level and an increase in 7-alpha-hydroxysteroid dehydrogenase (secondary bile acid biotransformation) than other clusters. In NAs-treated patients (n = 84), c-Bacteroides was associated with higher odds of plasma HBV-DNA undetectability when compared with non-c-Bacteroides clusters (OR 3.49, 95% CI 1.43–8.96, p = 0.01). c-Blautia was positively associated with advanced fibrosis (OR 2.74, 95% CI 1.09–7.31, p = 0.04). No such associations were found in treatment-naïve patients. Increased Escherichia coli relative abundance (0.21% vs. 0.03%, p = 0.035) was found in on-treatment patients (median treatment duration 98.1 months) with advanced fibrosis despite HBV DNA undetectability. An enrichment in l-tryptophan biosynthesis was observed in patients with advanced fibrosis, which exhibited a positive correlation with Escherichia coli.InterpretationCollectively, unique bacterial signatures, including c-Bacteroides and c-Blautia, were associated with virological undetectability and fibrosis evolution during NAs therapy in chronic HBV, setting up intriguing possibilities in optimizing HBV treatment.FundingThis study was supported by the Guangdong Natural Science Fund (2019A1515012003).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
深情安青应助YoungLee采纳,获得10
1秒前
逍遥完成签到,获得积分10
2秒前
汉堡包应助fg2477采纳,获得10
2秒前
木木完成签到,获得积分10
2秒前
今后应助言无间采纳,获得10
3秒前
ignus完成签到,获得积分10
3秒前
3秒前
XueXiTong完成签到,获得积分10
4秒前
研友_n01QxZ发布了新的文献求助10
5秒前
5秒前
自由的蒜苗完成签到,获得积分10
6秒前
含糊的尔槐应助恶恶么v采纳,获得50
7秒前
wang完成签到 ,获得积分10
7秒前
1751587229发布了新的文献求助10
7秒前
9秒前
chen完成签到,获得积分10
9秒前
10秒前
乐观海云完成签到 ,获得积分10
10秒前
暖阳完成签到,获得积分10
11秒前
Waris完成签到 ,获得积分10
11秒前
幸运娃娃完成签到 ,获得积分10
12秒前
13秒前
出其东门完成签到,获得积分10
13秒前
活泼的飞双完成签到,获得积分10
14秒前
14秒前
霸气的小土豆完成签到 ,获得积分10
14秒前
年轻豌豆完成签到 ,获得积分10
14秒前
14秒前
坚强寻凝发布了新的文献求助10
14秒前
猫男爵完成签到,获得积分10
17秒前
17秒前
谢小婷发布了新的文献求助10
18秒前
活泼万天完成签到,获得积分10
18秒前
安风完成签到 ,获得积分10
18秒前
坚定的又莲完成签到 ,获得积分10
18秒前
18秒前
酷波er应助屹舟采纳,获得10
18秒前
小闵完成签到,获得积分10
19秒前
映冬发布了新的文献求助10
19秒前
桐桐应助AHA采纳,获得20
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 生物化学 化学工程 物理 计算机科学 复合材料 内科学 催化作用 物理化学 光电子学 电极 冶金 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6022045
求助须知:如何正确求助?哪些是违规求助? 7639327
关于积分的说明 16167864
捐赠科研通 5170074
什么是DOI,文献DOI怎么找? 2766687
邀请新用户注册赠送积分活动 1749800
关于科研通互助平台的介绍 1636763